Medical & Healthcare Industry Analysis

Global Neoantigen cancer vaccines market expected to generate $35.5 million in revenue in 2024

The global neoantigen cancer vaccine industry analysis projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031.

Read More